A important advancement in diabetes treatment is emerging with the introduction of tirzepatide at a dosage of 45mg. This updated version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, https://zaynsylr848561.oneworldwiki.com/user